Stryker will pay a little over $79 million to end civil and criminal investigations conducted by the U.S. Department of Justice into the sales and marketing of the OtisKnee before Stryker acquired its parent company, OtisMed.
↧
Stryker will pay a little over $79 million to end civil and criminal investigations conducted by the U.S. Department of Justice into the sales and marketing of the OtisKnee before Stryker acquired its parent company, OtisMed.